Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix B Meeting Agenda First Meeting of the Committee on Daubert Standards January 27, 2005 Agenda 9:30 Handling Science in the PPA Litigation A Judge's Perspective Barbara J. Rothstein, Director, Federal Judicial Center 11:15 Wrestling with Causation in Tort Litigation Steven Goodman, Associate Professor of Oncology, Pediatrics, Epidemiology and Biostatistics, Johns Hopkins School of Medicine Michael D. Green, Bess and Walter Williams Distinguished Chair in Law, Wake Forest University Law School 12:00 Lunch 1:00 Breast Implants Panel of Expert Scientists Margaret Berger, Suzanne J. and Norman Miles Professor of Law, Brooklyn Law School Joe S. Cecil, Project Director, Program on Scientific and Technical Evidence, Federal Judicial Center 33
DISCUSSIONS OF THE COMMITTEE ON DAUBERT STANDARDS 2:45 Media Perspective: Academic Science and Drug Development David Korn, Senior Vice President, Association of American Medical Colleges Barry Meier, The New York Times 4:00 Improving the Gatekeeper's Decision-Making Shirley S. Abrahamson, Chief Justice, Wisconsin Supreme Court Marina Corodemus, Superior Court of New Jersey Barbara J. Rothstein, Director, Federal Judicial Center 5:15 Adjourn Second Meeting of the Committee on Daubert Standards March 27, 2005 Agenda 1:30 Daubert Revisited Areas Needing Further Study Committee Co-Chairs: Margaret Berger, Suzanne J. and Norman Miles Professor of Law, Brooklyn Law School Douglas Weed, Chief, Office of Preventive Oncology, National Cancer Institute, NIH 1. Evidence Synthesis in Science and Law A consider- ation of the different approaches used by scientists, lawyers, and judges in the selection, summarization, and interpretation of scientific evidence. 2. Involvement of Scientists in the Legal Process A consideration of how the Daubert decision has changed the involvement, role, and responsibilities of scientists in the courtroom, and opportunities and challenges for 34
Meeting Agenda more multi-disciplinary education and research in science and law. 3. Availability of Information A consideration of how courts and the public respond when scientific informa- tion is not forthcoming, whether because pertinent studies were never undertaken, or were conducted but never disclosed, or were sealed in settlement/secrecy agreements. 5:30 Adjourn 35